Director of Denali Therapeutics Inc. (NASDAQ:DNLI), Schenkein David P, sells 25,000 shares worth $2,251,555
According to Denali Therapeutics Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 23 09:52 PM, company Director, Schenkein David P disclosed selling 25,000 shares at a cost of $90.06. At the time of this transaction (Dec 21), this trade was worth $2,251,555 in total. As of Dec 21, Schenkein David P now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Denali Therapeutics Inc. (NASDAQ:DNLI) Director, Schenkein David P, we have the following information:
- SEC Form 4 filing: Dec 21: Sold 5,000 shares at the rate of $90.01 per share. Total worth of this trade was $450,027. Total number of shares owned as of Dec 21 were 26,232
- SEC Form 4 filing: Nov 12: Sold 30,000 shares at the rate of $70.05 per share. Total worth of this trade was $2,101,590. Total number of shares owned as of Nov 12 were 25,000
- SEC Form 4 filing: Nov 10: Sold 10,000 shares at the rate of $60.03 per share. Total worth of this trade was $600,310. Total number of shares owned as of Nov 10 were 55,000
Posted by
George Daniels
on Thursday December 24 2020, 10:45 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
